Colestid and Impaired gastric emptying - a phase IV clinical study of FDA data

Summary:

Impaired gastric emptying is reported as a side effect among people who take Colestid (colestipol hydrochloride), especially for people who are female, 60+ old, also take Cardizem, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Impaired gastric emptying when taking Colestid. It is created by eHealthMe based on reports of 2,172 people who have side effects when taking Colestid from the FDA, and is updated regularly.

What is Colestid?

Colestid has active ingredients of colestipol hydrochloride. It is often used in irritable bowel syndrome. eHealthMe is studying from 2,233 Colestid users. Check the latest studies of Colestid.

What is Impaired gastric emptying?

Impaired gastric emptying is found to be associated with 939 drugs and 829 conditions by eHealthMe. Check the latest studies of Impaired gastric emptying.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 29, 2026

2,172 people reported to have side effects when taking Colestid.
Among them, 16 people (0.74%) have Impaired gastric emptying.

Could Colestid cause Impaired gastric emptying?

Among these 16 people:

What is the gender of people who have Impaired gastric emptying when taking Colestid? *

female: 100 %
male: 0.0 %

What is the age of people who have Impaired gastric emptying when taking Colestid? *

What are other drugs people take besides Colestid? *

What are other side effects people have besides Impaired gastric emptying? *

Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 16 people, 100.00%
Pain: 16 people, 100.00%
Osteonecrosis Of Jaw (death of bone of jaw): 16 people, 100.00%
Osteolysis (dissolution of bone): 16 people, 100.00%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 16 people, 100.00%
Bone Neoplasm (tumour of bone): 16 people, 100.00%
Fainting (loss of consciousness and postural tone): 16 people, 100.00%
Neuralgia (pain in one or more nerves): 16 people, 100.00%
Cardiac Disorder: 16 people, 100.00%
Multiple Myeloma (cancer of the plasma cells): 16 people, 100.00%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 14 people, 87.50%

* Approximation only. Some reports may have incomplete information.

Do you take Colestid and have Impaired gastric emptying?

- Check whether Impaired gastric emptying is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Colestid:

Colestid (2,233 reports)

Browse all side effects of Colestid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Impaired gastric emptying:

Impaired gastric emptying (939 drugs)

Browse all the conditions that are associated with Impaired gastric emptying:

Impaired gastric emptying (829 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on colestipol hydrochloride (the active ingredients of Colestid) and Colestid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.